Australia markets closed

Esperion Therapeutics, Inc. (ESPR)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
6.99+0.54 (+8.37%)
At close: 04:00PM EDT
7.00 +0.01 (+0.14%)
Pre-market: 07:00AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close6.45
Bid6.17 x 1300
Ask7.40 x 1300
Day's range6.24 - 7.03
52-week range3.28 - 19.79
Avg. volume1,209,238
Market cap440.416M
Beta (5Y monthly)0.42
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Real World Data Analysis Reveals Nearly Half of All Adults at High Risk for ASCVD and Eligible for a Statin Were Not On Any Statin

    – Less than 1 in 10 were on any non-statin lipid lowering therapy – – Findings were shared at the National Lipid Association Scientific Sessions – ANN ARBOR, Mich., June 03, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) announced findings from a real-world analysis of more than 400,000 patients at high-risk for atherosclerotic cardiovascular disease (ASCVD). The findings were presented at the National Lipid Association Scientific Sessions in Scottsdale, Arizona. “While professional guidelines

  • GlobeNewswire

    Esperion to Participate in the 2022 Jefferies Global Healthcare Conference

    ANN ARBOR, Mich., June 02, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR), today announced that President and Chief Executive Officer, Sheldon Koenig, will present at the upcoming 2022 Jefferies Global Healthcare Conference on June 8th, 2022. Event:2022 Jefferies Global Healthcare ConferenceDate:Wednesday, June 8th, 2022Format:Presentation and 1:1 MeetingsTime:9:00 AM (ET)Webcast:Link A live audio webcast can be accessed on the investor and media section of the Esperion website at https://www.

  • GlobeNewswire

    Esperion Announces the Appointment of J. Martin Carroll to its Board of Directors

    ANN ARBOR, Mich., June 01, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced the appointment of J. Martin Carroll as Chairperson of Esperion’s Board of Directors. Mr. Carroll will serve as a Class I director with a term expiring at the 2023 annual meeting of stockholders. "On behalf of the Esperion team and our directors, I am excited to welcome Marty as Chairperson of the Esperion Board. With his significant experience, Marty will provide additional leadership and strategic guida